Epitalon is a synthetic peptide studied primarily in Russia and Eastern Europe for potential healthy-aging effects. It is a lab-made analogue of a pineal gland extract called epithalamin.
- Structure: Short peptide of four amino acids (Ala–Glu–Asp–Gly).
- Origin: First isolated and described by Russian researcher Vladimir Khavinson.
- Main proposed action: Modulates telomerase activity, which can help maintain telomeres—the protective caps at the ends of chromosomes.
Proposed Uses (Research Context)
- Healthy-aging research: Animal and limited human studies report telomere support and markers of slowed cellular aging.
- Immune and endocrine support: Reported effects include melatonin rhythm support and circadian regulation.
- Potential disease prevention: Early research has explored roles in ocular, cardiovascular, and oncologic risk modulation; human evidence remains limited.
How It Is Used (Research Settings)
- Administration: Most studies used injections (subcutaneous or intramuscular).
- Alternative forms: Oral or nasal products are marketed, but absorption and effectiveness are less established for peptides taken this way.
Typical Research Dosing
For informational purposes only; not medical advice.
- Common study pattern: 5–10 mg per day via injection for 10–20 days.
- Cycling: Short courses repeated annually or semi-annually (for example, every 6 months).
- Example protocol: 10 mg daily for 10 days, then a 6-month break before repeating.
Important Considerations
- Evidence base: Many studies are small and originate from a limited number of research groups; broader replication is limited.
- Safety: Generally reported as well tolerated short-term in studies; long-term safety in humans is not established.
- Regulatory status: Not FDA-approved in the U.S. and typically sold only as a research chemical or supplement in some markets.
Summary
Epitalon is an experimental peptide investigated for telomere support, sleep regulation, and markers of healthy aging. Use has primarily been within research contexts, and it is not an FDA-approved therapy.
Medical Disclaimer: The information on this page is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Epitalon is not approved by the FDA to diagnose, treat, cure, or prevent any disease.
At-a-Glance
- Delivery: Predominantly injection-based protocols in published reports.
- Duration: Short “pulsed” courses over 10–20 days rather than continuous daily use.
- Rationale: Proposed bioregulatory “signal peptide” effect—brief exposure may help reset gene expression pathways related to telomerase and circadian function.
- Reported outcomes: Studies describe improvements in sleep quality and selected biomarkers in older adults; robust, large-scale Western trials are lacking.